Todd E. Simpson's most recent trade in Xencor Inc was a trade of 27,372 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xencor Inc | Todd E. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,372 | 27,372 | - | - | Stock Option (Right to Buy) | |
| Xencor Inc | Todd E. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 13,686 | 13,686 (0%) | 0% | 0 | Common Stock | |
| Xencor Inc | Todd E. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 43,337 | 43,337 | - | - | Stock Option (Right to Buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 1,225 | 131,410 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 206.00 per share. | 28 Aug 2023 | 485 | 130,925 (0%) | 0% | 206 | 99,910 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 14,746 | 133,692 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 193.87 per share. | 15 Aug 2023 | 1,540 | 130,185 (0%) | 0% | 193.9 | 298,558 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 193.87 per share. | 15 Aug 2023 | 1,106 | 132,586 (0%) | 0% | 193.9 | 214,419 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 193.87 per share. | 15 Aug 2023 | 861 | 131,725 (0%) | 0% | 193.9 | 166,921 | Common Stock |
| Neoleukin Therapeutics Inc | Todd E. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.37 per share. | 10 Apr 2023 | 40,364 | 159,310 (0%) | 0% | 46.4 | 1,871,679 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2023 | 40,364 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 204.74 per share. | 10 Apr 2023 | 40,364 | 118,946 (0%) | 0% | 204.7 | 8,264,125 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.37 per share. | 10 Apr 2023 | 14,980 | 133,926 (0%) | 0% | 46.4 | 694,623 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2023 | 14,980 | 40,364 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 204.14 per share. | 10 Apr 2023 | 14,980 | 118,946 (0%) | 0% | 204.1 | 3,058,017 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 1,395 | 118,580 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 42,793 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.30 per share. | 09 Mar 2023 | 42,793 | 159,978 (0%) | 0% | 45.3 | 1,938,523 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 176.71 per share. | 09 Mar 2023 | 26,449 | 123,267 (0%) | 0% | 176.7 | 4,673,803 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 175.89 per share. | 09 Mar 2023 | 10,262 | 149,716 (0%) | 0% | 175.9 | 1,804,983 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 177.37 per share. | 09 Mar 2023 | 6,082 | 117,185 (0%) | 0% | 177.4 | 1,078,764 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 182.53 per share. | 27 Feb 2023 | 20,000 | 117,185 (0%) | 0% | 182.5 | 3,650,600 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 39,946 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 16 Feb 2023 | 39,946 | 137,185 (0%) | 0% | 160.0 | 6,391,400 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.15 per share. | 16 Feb 2023 | 39,946 | 177,131 (0%) | 0% | 39.2 | 1,563,886 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 154.41 per share. | 31 Aug 2022 | 2,122 | 139,249 (0%) | 0% | 154.4 | 327,668 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 154.41 per share. | 31 Aug 2022 | 2,064 | 137,185 (0%) | 0% | 154.4 | 318,712 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 15,447 | 143,338 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 170.22 per share. | 15 Aug 2022 | 1,106 | 141,371 (0%) | 0% | 170.2 | 188,258 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 170.21 per share. | 15 Aug 2022 | 861 | 142,477 (0%) | 0% | 170.2 | 146,555 | Common Stock |
| Neoleukin Therapeutics Inc | Todd E. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 149.85 per share. | 20 Dec 2021 | 345 | 128,458 (0%) | 0% | 149.8 | 51,698 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2021 | 40,232 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 185.00 per share. | 03 Nov 2021 | 40,232 | 126,647 (0%) | 0% | 185 | 7,442,920 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.09 per share. | 03 Nov 2021 | 40,232 | 166,879 (0%) | 0% | 44.1 | 1,773,829 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2021 | 2,156 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.37 per share. | 03 Nov 2021 | 2,156 | 128,803 (0%) | 0% | 46.4 | 99,974 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.04 per share. | 29 Oct 2021 | 33,564 | 160,211 (0%) | 0% | 41.0 | 1,377,467 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 33,564 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 29 Oct 2021 | 33,564 | 126,647 (0%) | 0% | 180.0 | 6,041,523 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 166.22 per share. | 23 Sep 2021 | 201 | 126,647 (0%) | 0% | 166.2 | 33,410 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 167.52 per share. | 31 Aug 2021 | 2,122 | 126,446 (0%) | 0% | 167.5 | 355,468 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 167.52 per share. | 31 Aug 2021 | 1,865 | 128,568 (0%) | 0% | 167.5 | 312,416 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 26,427 | 26,427 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 11,095 | 130,433 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 642 | 642 | - | - | Incentive Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 154.55 per share. | 16 Aug 2021 | 533 | 119,338 (0%) | 0% | 154.6 | 82,377 | Common Stock |
| Neoleukin Therapeutics Inc | Todd E. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 18 Dec 2020 | 33,669 | 118,767 (0%) | 0% | 200 | 6,733,800 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.10 per share. | 18 Dec 2020 | 33,669 | 152,436 (0%) | 0% | 26.1 | 878,761 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2020 | 33,669 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2020 | 1,104 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.30 per share. | 18 Dec 2020 | 1,104 | 119,871 (0%) | 0% | 45.3 | 50,011 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 180.37 per share. | 05 Nov 2020 | 7,509 | 118,767 (0%) | 0% | 180.4 | 1,354,383 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 155.74 per share. | 31 Aug 2020 | 5,480 | 128,435 (0%) | 0% | 155.7 | 853,455 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 155.25 per share. | 31 Aug 2020 | 4,452 | 133,915 (0%) | 0% | 155.3 | 691,173 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 155.69 per share. | 31 Aug 2020 | 2,122 | 138,367 (0%) | 0% | 155.7 | 330,383 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 155.69 per share. | 31 Aug 2020 | 2,065 | 140,489 (0%) | 0% | 155.7 | 321,509 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 156.87 per share. | 31 Aug 2020 | 1,640 | 126,795 (0%) | 0% | 156.9 | 257,267 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 159.33 per share. | 31 Aug 2020 | 469 | 126,276 (0%) | 0% | 159.3 | 74,726 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 157.82 per share. | 31 Aug 2020 | 50 | 126,745 (0%) | 0% | 157.8 | 7,891 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 158.17 per share. | 18 Aug 2020 | 9,262 | 142,554 (0%) | 0% | 158.2 | 1,464,959 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 20,774 | 20,774 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 8,635 | 151,816 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 636 | 636 | - | - | Incentive Stock Option (right to buy) | |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 166.10 per share. | 03 Aug 2020 | 10,375 | 145,086 (0%) | 0% | 166.1 | 1,723,288 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 164.96 per share. | 03 Aug 2020 | 7,720 | 155,461 (0%) | 0% | 165.0 | 1,273,491 | Common Stock |
| Seagen Inc | Todd E. Simpson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 166.74 per share. | 03 Aug 2020 | 1,905 | 143,181 (0%) | 0% | 166.7 | 317,640 | Common Stock |